Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors; Aggressive FibromatosisIntervention: Drug: PF-03084014Sponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials